High Court ruling against Novartis and Bayer: Implications
Claudia Rubin and Tom Jaggs explore the implications of the High Court ruling against Novartis and Bayer for pharma.
High Court ruling against Novartis and...
NHS long-term plan: Growing importance of prevention medicine
“The challenge now is for the NHS to respond to this changing landscape and to focus on preventing as well as treating the conditions...
Have analytics been relegated to a reporting function?
Have business analytics been pushed to the background? Business information upgraded, smart CRM datasets, the Predictive Analytics silver bullet and other fairy tales.
Is Brexit good news for pharma?
James Burt, Executive Vice President EMENA, Accord Healthcare, asks whether Brexit will in fact present an opportunity for positive change in pharma and healthcare.
What do NHS changes mean for tech innovation?
Could changes at the top mean fresh opportunities for tech innovation?
Read this in the August issue of Pf Magazine.
For some time it has been...
At the heart of it: The vital role of pharmacies in community health
Read this in the August issue of Pf Magazine.
Community pharmacy has a clear role in promoting and supporting the public’s health. There’s an accessible...
Five ways blockchain is impacting healthcare
Blockchain is one of the most talked about technologies at the moment and boasts huge potential to transform how we deliver healthcare and revolutionise...
Brexit: What will it mean for the regulation of medicines?
What are the implications for the movement of medicines from and into the UK, post-brexit? Mark Quick, executive vice president of corporate development at Recipharm, comments on the current situation and the potential implications of the UK exiting the European Union (EU).
The five key areas to drive growth of UK’s pharmaceutical sector
These 5 things are what pharmaceutical companies should be focusing on to maximise their growth in the UK.
The NHS is 70 – Claudia Rubin asks: what’s next?
From birthday teas to big policy, blood donor drives to special 10p coins, the 70th anniversary of the creation of the NHS is getting...
Latest articles
Novo Nordisk presents oral semaglitude data at ENDO
Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners on the positive patient outcomes that come from working together
The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Detecting and managing atrial fibrillation
The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Popular articles
Detecting and managing atrial fibrillation
The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)
Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics and precision medicine
How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Novo Nordisk presents oral semaglitude data at ENDO
Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Addressing the skills shortage in life sciences
How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...